Aspirin and fibrinolysis in acute myocardial infarction: Meta-analytic evidence for synergy
- 31 December 1991
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 44 (10), 1085-1096
- https://doi.org/10.1016/0895-4356(91)90011-w
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarctionJournal of the American College of Cardiology, 1989
- Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.BMJ, 1988
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.Circulation, 1988
- The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.Circulation, 1988
- A Randomized Trial of Intravenous Tissue Plasminogen Activator for Acute Myocardial Infarction with Subsequent Randomization to Elective Coronary AngioplastyNew England Journal of Medicine, 1987
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Randomized double-blind trial of intravenous streptokinase for acute myocardial infarctionThe American Journal of Cardiology, 1986
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- GUY'S HOSPITAL.The Lancet, 1823